Significant improvement of quality of life following atrioventricular synchronous pacing in patients with hypertrophic obstructive cardiomyopathy. Data from 1 year of follow-up

European Heart Journal

Volumn 20, Issue 14, 1999, Pages 1044-1050

  Gadler, F ^a   Linde, C ^a   Daubert, C ^a   McKenna, W ^a   Meisel, E ^a   Aliot, E ^a   Chojnowska, L ^a   Guize, L ^a   Gras, D ^a   Jeanrenaud, X ^a   Kappenberger, L ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Hypertrophic obstructive cardiomyopathy; Pacing; Quality of life

Indexed keywords

ADULT; AGED; ARTICLE; ARTIFICIAL HEART PACEMAKER; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; FEMALE; HEART ARRHYTHMIA; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; TREATMENT FAILURE;

ADULT; AGED; AGED, 80 AND OVER; CARDIAC PACING, ARTIFICIAL; CARDIOMYOPATHY, HYPERTROPHIC; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIALS;

EID: 0033168641     PISSN: 0195668X     EISSN: None     Source Type: Journal    
DOI: 10.1053/euhj.1998.1331     Document Type: Article

References (19)

1. Seiler C, Hess OM, Schoenbeck M et al. Long-term follow-up of medical versus surgical therapy for hypertrophic cardiomyopathy: A retrospective study. J Am Coll Cardiol 1991; 17: 634-42.
2. Blanchard DG, Ross J. Hypertrophic cardiomyopathy: Prognosis with medical or surgical therapy. Clin Cardiol 1991; 14: 11-9.
3. Jeanrenaud X, Goy JJ, Kappenberger L. Effects of dualchamber pacing in hypertrophic obstructive cardiomyopathy. Lancet 1992; 339: 1318-23.
4. Gadler F, Linde C, Juhlin-Dannfelt A, Ribeiro A, Rydén L. Influence of right ventricular pacing site on left ventricular outflow tract obstruction in patients with hypertrophic obstructive cardiomyopathy. J Am Coll Cardiol 1996; 27: 1219-24.
5. Fananapazir L, Epstein ND, Curiel RV, Panza JA, Tripodi D, McAvreavey D. Long-term results of dual chamber (DDD) pacing in obstructive hypertrophic cardiomyopathy. Evidence of progressive symptomatic and hemodynamic improvement and reduction of left ventricular hypertrophy. Circulation 1994; 90: 2731-42.
6. Slade A, Sadoul N, Shapiro L et al. DDD pacing in hypertrophic cardiomyopathy: A multicenter clinical experience. Heart 1996; 75: 44-9.
7. Gadler F, Linde C, Juhlin-Dannfelt A, Ribeiro A, Rydén L. Long-term effects of dual chamber pacing in patients with hypertrophic obstructive cardiomyopathy without outflow obstruction at rest. Eur Heart J 1997; 18: 636-42.
8. Kappenberger L, Linde C, Daubert C et al. Pacing in hypertrophic obstructive cardiomyopathy (PIC). A randomised crossover study. Eur Heart J 1997; 18: 1249-56.
9. Linde-Edelstam, Nordlander R, Undén A-L, Orth-Gomér K, Rydén L. Quality of life in patients treated with atrioventricular synchronous pacing compared to rate modulated ventricular pacing: A long-term, double blind, crossover study. PACE 1992; 15: 1467-76.
10. Undén AL, Schenck-Gustavsson K, Axelsson PO, Karlsson I, Orth-Gomér K, Ydrefors A. Positive effects of increase nurse support for male patients after acute myocardial infarction. Qual Life Res 1993; 2: 121-7.
11. Epidemiology of cardiovascular diseases methodology. Am Heart Ass.-National Heart Inst., Suppl to Am J Publ Health and the Nations Health. 1960; 30: 10.
12. Hinkle LE, Whitney LH, Lehman EW et al. Occupation, education and coronary heart disease. Risk is influenced more by education and background than by occupational experiences, in the Bell system. Science 1968; 161: 238-46.
13. Rose GA, Blackburn H. Cardiovascular Survey Methods. Geneva: WHO 1986 56: 1-188.
14. Orth-Gomér K, Undén A-L, Edwards ME. Social isolation and mortality in ischemic heart disease. A 10-year follow-up study of 150 middle-aged men. Acta Med Scand 1988; 224: 205-15.
15. Sjöberg I, Svensson E, Persson LO. The measurement of mood. Scand J Psychol 1979; 20: 1-18.
16. Guyatt GH. Measurement of health related quality of life in heart failure. J Am Coll Cardiol 1993; 4: 185A-191A.
17. Maron BJ. Hypertrophic cardiomyopathy. Curr Probl Cardiol 1993; 18: 639-704.
18. Nishimura RA, Trusty J, Hayes DL et al. Dual-chamber pacing for hypertrophic cardiomyopathy: A randomised, double-blind, crossover trial. J Am Coll Cardiol 1997; 29: 435-41.
19. Hansen BJ, Meyhoff HH, Nordling J, Mensik HJA, Modensen P, Højkjær Laresen E and the ALFECH study group. Placebo effects in the pharmacological treatment of uncomplicated benign prostatic hyperplasia. Scand J Urol Nephrol 1996; 30: 373-7.